Background. Despite major technical improvements in the care of children requiring renal replacement therapy (RRT) before 2 years of age, the management of those patients remains challenging and transplantation is generally delayed until the child weighs 10 kg or is 2 years old. In this national cohort study, we studied patient and graft survival in children starting RRT before 2 years of age to help clinicians and parents when deciding on RRT initiation and transplantation management. Methods. All children starting RRT before 24 months of age between 1992 and 2012 in France were included through the national Renal Epidemiology and Information Network (REIN) registry. The primary endpoints were patient survival on dialysis and 10-year graft survival. Results. A total of 224 patients were included {62% boys, median age 10.5 months [interquartile range (IQR) 5.8-15.6]}. The 10-year survival rate was 84% (IQR 77-89). Suffering from extrarenal comorbidities was the only factor significantly associated with both an increased risk of death on dialysis [hazard ratio 5.9 (95% confidence interval 1. 8-19.3)] and a decreased probability of being transplanted. During follow-up, 174 renal transplantations were performed in 171 patients [median age at first transplantation 30.2 (IQR 21.8-40.7) months]. The 10-year graft survival was 74% . Factors associated with graft loss in multivariate analysis were the time spent on dialysis before
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I N T R O D U C T I O N
End-stage renal disease (ESRD) is a rare condition in infants and young children. The incidence of ESRD in children <4 years of age is 5.2 per million age-related inhabitants in France [1] and 6.5 per million age-related inhabitants in Europe [2] . Despite major technical improvements in the care of children requiring renal replacement therapy (RRT) before 2 years of age, the management of these patients remains challenging [3, 4] . Renal transplantation is generally delayed until the child weighs 10 kg or is 2 years old, thus exposing the youngest patients to a prolonged period of dialysis and major issues in terms of nutrition, growth and psychomotor development.
Moreover, extrarenal comorbidities are frequent in this group because more than half of the primary renal diseases (PRDs) in this age group are genetic diseases with potential extrarenal involvement [1] and because prenatal renal failure potentially complicated by oligoamnios or anamnios exposes some of these patients to pulmonary hypoplasia, premature birth and its complications.
However, major improvement in the survival of these patients has been reported over the last decades. Mitsfenes et al. [5] reported a decrease in the mortality rate from 11.2% in the early 1990s to 8.3% between 2005 and 2010 in the USA, while McDonald and Craig [6] , based on data from the Australia and New Zealand Dialysis and Transplant Registry, reported a decrease in the risk ratio of death from 116 to 32 when compared with the age-related mortality of the general population between the 1960s and the 1990s. Despite the progress made, initiating RRT, especially in the youngest children, remains controversial. Geary performed two surveys, one in 1998 and one in 2010: they found that clinical management perspectives have not substantially changed since RRT was offered by 41% of the nephrologists to all infants <1 month and by 53% to all infants between 1 and 12 months in 1998 and by 30 and 50%, respectively, in 2010 [7, 8] . Today, many paediatric nephrologists still consider RRT in infants as an optional rather than a mandatory treatment [9, 10] .
Considering renal transplantation, graft survival has been consistently reported to be worse in the youngest children when compared with older ones [1] . Although many studies have investigated the impact of morphological [11] [12] [13] and immunological matching [14, 15] on graft survival, major discrepancies in the minimal recipient weight for renal transplantation, the choice of deceased versus living donor and minimal human leucocyte antigen (HLA) matching have been reported between centres and countries [16] . Moreover, no study has investigated the impact of these factors together. Thus we aim to study patient and graft survival in children starting RRT before 2 years of age to help clinicians and parents make decisions on RRT initiation and transplantation programming.
M A T E R I A L S A N D M E T H O D S

Study population and data
We included all patients who started RRT before 24 months of age in France between 1 January 1992 and 31 December 2012. In order to be exhaustive, three complementary ways of detecting patients were used: the national transplant database (CRISTAL), which records data on all the patients registered on the waiting list since 1992; the Renal Epidemiology and Information Network Registry, which records data on all patients on RRT and is exhaustive in children since 2005; and all individual hospital databases.
Patient characteristics recorded were age at RRT initiation and at renal transplant; sex; PRD, which were classified in four groups [congenital abnormalities of the kidney and the urinary tract (CAKUT), genetic diseases, vascular diseases and others]; first RRT modality [peritoneal dialysis (PD), haemodialysis (HD) or pre-emptive transplantation); comorbidities (including neurological abnormality, liver disease, heart disease and respiratory insufficiency, from which we created the binary variable 'at least one comorbidity'); and date of death if applicable.
Data on the transplantation included age at renal transplant, weight and height of the donor and the recipient, type of donor (living or deceased), HLA matching and cold ischaemia time.
Statistical analysis
For descriptive analysis, continuous variables are given as median and interquartile range (IQR) and dichotomous variables as number and percentage.
Patients' survival and access to renal transplantation. We present the cumulative incidence of death and transplantation overall and stratified by risk factors. In order to assess the factors associated with the risk of death on dialysis, we used univariate and multivariate Cox proportional hazards regression, with the time between the start of RRT and death as the primary outcome and renal transplantation as a censoring event.
Patients who received pre-emptive transplantation (n ¼ 7) were excluded from this analysis. All variables with a P-value of 0.20 in the univariate analysis were included in the multivariate analysis. We tested for the presence of a cohort effect by testing the association between the year at RRT initiation and death with the SAS macro RCS-REG (SAS Institute, Cary, NC, USA), which tests both the linearity and the significance of the association using spline modelling.
Renal transplant survival. The primary outcome was a composite outcome defined as graft loss or death. We used univariate Cox regression to assess the association between each variable and the outcome. The proportional hazards assumption of the models was assessed by graphical methods. All continuous variables were tested for linearity with the SAS macro RCS-REG. We used Kaplan-Meier modelling to present the survival curve. Multivariate Cox regression was used to assess factors associated with graft loss.
R E S U L T S
We included 224 patients who started RRT before 24 months of age. Among them, 141 (62.9%) were male, the median age at RRT initiation was 10.4 (IQR 5.8-15.6) months and the most prevalent PRDs were CAKUT and genetic diseases. Of these, 48 patients presented at least one extrarenal comorbidity, including 21 patients with associated neurological abnormalities, 20 patients with associated liver diseases, 14 patients with heart diseases and 5 patients with concomitant respiratory insufficiency. A flow chart of the cohort is presented as Supplementary data, Figure S1 and patients' characteristics at RRT initiation are presented in Table 1 .
The median follow-up time was 78 (IQR 36-147) months. During follow-up, 174 renal transplantations were performed in 171 patients; 29 patients died (18 before renal transplantation and 11 after renal transplantation) and the mortality rate on dialysis was 40 deaths per 1000 person-years compared with 9 deaths for 1000 person-years after transplantation. The two main causes of death were infections and cardiovascular events (Table 2 ). Only 10 transplantations were performed from a living donor. Overall the 5-and 10-year survivals were 87% (IQR 82-91) and 84% (IQR 77-89), respectively.
Determinants of patient survival on dialysis and access to transplantation
Overall, 217 patients started RRT with dialysis and were included in this analysis. Patients' characteristics found to be associated with an increased risk of death by univariate analysis were having a genetic disease as the PRD [HR 5.6 (95% CI 1.3-25.0)] as compared to patients with CAKUT} and the presence of one or more extra-renal comorbidities [HR 7.7 (95% CI 2.4-24.5)]. There was a trend towards a decreased risk of death with age, although it did not reach statistical significance. Starting RRT on PD or HD did not significantly impact patient survival.
Suffering from extrarenal comorbidities was the only factor significantly associated in multivariate analysis with both the hazard of death [HR 5.9 (95% CI 1.8-19.3)] (Table 3 ) and the hazard of being transplanted (data not shown). Supplementary data, Figures S2 and S3 present the cumulative incidence of death and renal transplantation stratified on the presence of comorbidity and on the different age groups, respectively.
Determinants of graft survival
The 10-year graft survival was 74% (IQR 67-81). Figure 1 presents the graft survival curve.
Over the 171 first renal transplantations performed in our patients, the median dialysis time prior to transplantation was 22.1 (IQR 10.1-33.4) months, the median age at transplantation was 30.2 (IQR 21.8-40.7) months and the median recipient weight and height were 12.0 (IQR 10.4-13.6) kg and 85.0 (IQR 80.5-92.5) cm, respectively. Overall, our population of recipients was very homogeneous, with only 5% of the recipients <1 year old. They were very close in terms of weight and height. This homogeneity precluded us from studying the impact of those variables on renal survival. Variables found to be Patient and transplant outcome in infants associated with graft survival by univariate analysis were the donor/recipient height ratio (P ¼ 0.05), the number of human leucocyte antigen-antigen D-related (HLA-DR) mismatches (P ¼ 0.02) and the time spent on dialysis prior to renal transplantation (P ¼ 0.001) ( Table 4) . In order to make our results potentially useful in clinical practice, we dichotomized the donor/recipient height ratio in five categories (ratio 1, 1 < ratio < 1.4, 1.4 ratio 1.8, 1.8 < ratio < 2.2 and ratio ! 2.2). The three factors found significantly associated with graft loss in multivariate analysis were the time spent on dialysis before transplantation, donor/recipient height ratio and presenting two HLA-DR mismatches (Table 5) .
D I S C U S S I O N
In this national cohort of patients starting RRT before the age of 2 years, we confirmed the overall good patient survival with a 5-year survival of 87%, close to the survival reported in the USA in patients 0-4 years of age (84%) [17] .
As reported in many previous studies [5, 6, 18, 19] , we found a trend towards an increased risk of death in the youngest children, although age at RRT initiation did not reach statistical significance. Carey et al. [20] did not find a significant difference in survival between patients starting RRT before 1 month and those starting between 1 and 24 months of age; however, because North American Pediatric Renal Trials and Collaborative Studies only includes patients who started dialysis in centres willing to participate in the registry, selection bias of the youngest patients with the most favourable prognosis might explain the absence of effect of age at initiation of RRT in this study. In our study, the only factor significantly associated with patient survival was the presence of extrarenal comorbidities, with a cumulative incidence of death ranging from 4% in patients without extrarenal comorbidities to 30% in patients with at least one comorbidity. This is consistent with the data published by Wedekin et al. [21] in a cohort of patients starting RRT at <1 year of age and with the causes of death reported in The Netherlands in ESRD patients 0-14 years of age treated between 1972 and 1992 [22] . Similarly, a study focusing on patients with CAKUT demonstrated that the major risk factor of death was the association with extrarenal abnormalities [23] . In our study, no difference in survival was found between patients starting RRT with HD or PD. This result is consistent with a recent publication from the European Society of Paediatric Nephrology/European Renal AssociationEuropean Dialysis and Transplant Association (ESPN/ERA-EDTA) registry that did not find any difference in survival between HD and PD in patients starting RRT before the age of 1 year [24] . Nevertheless, the overall survival of infants starting RRT remains lower than the survival of older children [17] , even though their survival post-transplantation is excellent and not different from the survival of older children [21] . However, many studies have emphasized the issues raised by renal transplantation in this population. Should we favour living kidney donation, usually from adults with major morphological differences? Is HLA matching still important in infants? However, mixing all these results together to guide clinical decisions remains challenging, so that there is a great heterogeneity of practices. In our study, morphological matching, especially in height, was highly associated with graft survival and a donor/recipient height ratio between 1.4 and 1.8 was found to be associated with the best graft survival. One of the main causes of graft loss in patients <2 years of age at transplantation is vascular thrombosis [25, 26] , and many studies have reported worse graft outcomes when using age-matched donors. A recent study from the ESPN/ERA-EDTA registry confirmed the increased risk of graft loss in children receiving a transplant from a deceased donor <5 years of age [27] . Moreover, Dick et al. [12] found decreased renal survival among adolescent recipients who received a kidney from a smaller donor (donor/recipient body surface area ratio < 0.9), confirming the risk associated with smaller donors [12] . Pape et al. [28] , studying children <10 years of age, questioned the use of kidneys from adult donors, because they found that 3-5 years after transplantation the corrected glomerular filtration rate (GFR) was significantly higher in children who had received a paediatric graft, with grafts also doubling in size, whereas no increase in size was noted in adult grafts. Our study confirms that in the youngest patients the use of height-matched kidneys increases the risk of graft loss and should therefore be avoided. Moreover, the scarcity of small paediatric kidney donors would lead to unacceptable waiting times on dialysis [11] . Our study also shows that a long time on dialysis prior to transplantation is associated with an increased risk of graft loss. Thus the benefit of waiting for an optimal transplant in terms of HLA and size matching might be outweighed by the negative impact of a long waiting time. This finding calls for regular and individualized re-evaluation of the requirements regarding transplant characteristics as time on dialysis increases.
The other factor found to be significantly associated with graft survival in our patients was HLA matching for Class 2 antigen DR. Recently, authors have questioned the importance of HLA matching [29] and emphasized the importance of other factors such as prioritizing kidney from young adults for paediatric recipients [14] and minimizing cold ischaemia time. Moreover, not waiting for an HLA-matched kidney could favour rapid access to transplantation and allow pre-emptive transplantation in some children. However, poorer HLA matching, especially in Class 2, harbours the risk of de novo development of panel reactive antibodies (PRA) that could 
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Patient and transplant outcome in infants hamper both the ability to receive subsequent transplantation and graft survival [30] . This is a major concern in young children receiving renal transplantation since they will require several transplantations in their lifetime. Moreover, this issue remains unclear, as Gritsch et al. [14] did not find any difference in PRA level between well-matched and unmatched patients. Recently, Tinckam et al. [31] also reported on the risk of repeated HLA mismatch and showed that the presence of HLA Class 2 mismatches and PRA before the second transplantation decreases graft survival. This effect was even stronger in patients who underwent a nephrectomy of the first transplant. Finally, the major issue faced by clinicians when considering the optimal strategy of transplantation is to combine all the data together to make evidence-based decisions. Among adults, several authors have created clinical scores aimed at predicting renal transplantation outcome based on pretransplant [32] and post-transplant data [33] [34] [35] [36] . Among children, a study aimed at defining groups of patients by the risk of graft loss has been recently published based on data from the ESPN/ERA-EDTA registry [37] . However, patients starting RRT before 2 years of age require specific studies focusing on this population and will require international collaboration.
Based on the data of this national cohort, we were able to confirm and specify risk factors of patient and transplant survival in the youngest children starting RRT. Our study also has some limitations. First, the retrospective design of the study and the absence of termination of pregnancy and conservative treatments induces a selection bias since the study of patient survival does not apply to all patients with ESRD but to those who started RRT. Moreover, practices of RRT initiation differ between countries and centres. Due to the scarcity of patients starting RRT before 2 years of age, we included patients over a 20-year period. Although we did not find any statistically significant cohort effect, modifications of practices could modify the association reported. Similarly, given the scarcity of these patients, we grouped the PRDs into five categories; this did not allow us to study the impact of each specific disease on the outcomes. Finally, the scarcity of transplantation from living donors precluded us from comparing graft survival by the type of donor.
C O N C L U S I O N
In this national retrospective cohort study, we confirm the overall good outcome of children starting RRT before 2 years of age, especially in the absence of extrarenal comorbidities. Thus the main questions in infants with ESRD remain when and how to transplant them. Our study provides data on the optimal morphological and immunological matching in order to help clinicians in their decisions. By extending this analysis to other cohorts, we aim to develop a tool that is able to predict graft loss and help clinicians when choosing the optimal kidney for their patients.
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